["[Tab] The Boeing Company and Subsidiaries Consolidated Statements of Cash Flows\n\n[Time]: December 31, 2023 [SEP]\n[row 0]: Cash flows \u2013 operating activities: [SEP]\n[row 1]: Net loss | $(2,242) [SEP]\n[row 2]: Share-based plans expense | $690 [SEP]\n[row 3]: Treasury shares issued for 401(k) contribution | $1,515 [SEP]\n[row 4]: Depreciation and amortization | $1,861 [SEP]\n[row 5]: Investment/asset impairment charges, net | $46 [SEP]\n[row 6]: Gain on dispositions, net | $(2) [SEP]\n[row 7]: 787 reach-forward loss | $3 [SEP]\n[row 8]: Other charges and credits, net | $3 [SEP]\n[row 9]: Accounts receivable | ($128) [SEP]\n[row 10]: Unbilled receivables | $321 [SEP]\n[row 11]: Advances and progress billings | $3,365 [SEP]\n[row 12]: Inventories | $(1,681) [SEP]\n[row 13]: Other current assets | $389 [SEP]\n[row 14]: Accounts payable | $1,672 [SEP]\n[row 15]: Accrued liabilities | $779 [SEP]\n[row 16]: Income taxes receivable, payable and deferred | $44 [SEP]\n[row 17]: Other long-term liabilities | $(313) [SEP]\n[row 18]: Pension and other postretirement plans | $(1,049) [SEP]\n[row 19]: Financing receivables and operating lease equipment, net | $571 [SEP]\n[row 20]: Other | $119 [SEP]\n[row 21]: Net cash provided/(used) by operating activities | $5,960 [SEP]\n\n[row 22]: Cash flows \u2013 investing activities: [SEP]\n[row 23]: Payments to acquire property, plant and equipment | $(1,527) [SEP]\n[row 24]: Proceeds from disposals of property, plant and equipment | $27 [SEP]\n[row 25]: Acquisitions, net of cash acquired | $(70) [SEP]\n[row 26]: Contributions to investments | $(16,448) [SEP]\n[row 27]: Proceeds from investments | $15,739 [SEP]\n[row 28]: Other | $(158) [SEP]\n[row 29]: Net cash (used)/provided by investing activities | $(2,437) [SEP]\n\n[row 30]: Cash flows \u2013 financing activities: [SEP]\n[row 31]: New borrowings | $75 [SEP]\n[row 32]: Debt repayments | $(5,216) [SEP]\n[row 33]: Stock options exercised | $45 [SEP]\n[row 34]: Employee taxes on certain share-based payment arrangements | $(408) [SEP]\n[row 35]: Other | $17 [SEP]\n[row 36]: Net cash used by financing activities | $(5,487) [SEP]\n\n[row 37]: Effect of exchange rate changes on cash and cash equivalents | $30 [SEP]\n[row 38]: Net (decrease)/increase in cash & cash equivalents, including restricted | $(1,934) [SEP]\n[row 39]: Cash & cash equivalents, including restricted, at beginning of year | $14,647 [SEP]\n[row 40]: Cash & cash equivalents, including restricted, at end of year | $12,713 [SEP]\n[row 41]: Less restricted cash & cash equivalents, included in Investments | $22 [SEP]\n[row 42]: Cash and cash equivalents at end of year | $12,691 [SEP]\n\n[Time]: December 31, 2022 [SEP]\n[row 0]: Cash flows \u2013 operating activities: [SEP]\n[row 1]: Net loss | $(5,053) [SEP]\n[row 2]: Share-based plans expense | $725 [SEP]\n[row 3]: Treasury shares issued for 401(k) contribution | $1,215 [SEP]\n[row 4]: Depreciation and amortization | $1,979 [SEP]\n[row 5]: Investment/asset impairment charges, net | $112 [SEP]\n[row 6]: Gain on dispositions, net | $(6) [SEP]\n[row 7]: 787 reach-forward loss | $401 [SEP]\n[row 8]: Other charges and credits, net | $401 [SEP]\n[row 9]: Accounts receivable | $142 [SEP]\n[row 10]: Unbilled receivables | $6 [SEP]\n[row 11]: Advances and progress billings | $108 [SEP]\n[row 12]: Inventories | $(420) [SEP]\n[row 13]: Other current assets | $(591) [SEP]\n[row 14]: Accounts payable | $838 [SEP]\n[row 15]: Accrued liabilities | $2,956 [SEP]\n[row 16]: Income taxes receivable, payable and deferred | $1,347 [SEP]\n[row 17]: Other long-term liabilities | $(158) [SEP]\n[row 18]: Pension and other postretirement plans | $(1,378) [SEP]\n[row 19]: Financing receivables and operating lease equipment, net | $142 [SEP]\n[row 20]: Other | $307 [SEP]\n[row 21]: Net cash provided/(used) by operating activities | $3,512 [SEP]\n\n[row 22]: Cash flows \u2013 investing activities: [SEP]\n[row 23]: Payments to acquire property, plant and equipment | $(1,222) [SEP]\n[row 24]: Proceeds from disposals of property, plant and equipment | $35 [SEP]\n[row 25]: Acquisitions, net of cash acquired |  [SEP]\n[row 26]: Contributions to investments | $(5,051) [SEP]\n[row 27]: Proceeds from investments | $10,619 [SEP]\n[row 28]: Other | $(11) [SEP]\n[row 29]: Net cash (used)/provided by investing activities | $4,370 [SEP]\n\n[row 30]: Cash flows \u2013 financing activities: [SEP]\n[row 31]: New borrowings | $34 [SEP]\n[row 32]: Debt repayments | $(1,310) [SEP]\n[row 33]: Stock options exercised | $50 [SEP]\n[row 34]: Employee taxes on certain share-based payment arrangements | $(40) [SEP]\n[row 35]: Other | [SEP]\n[row 36]: Net cash used by financing activities | $(1,266) [SEP]\n\n[row 37]: Effect of exchange rate changes on cash and cash equivalents | $(73) [SEP]\n[row 38]: Net (decrease)/increase in cash & cash equivalents, including restricted | $6,543 [SEP]\n[row 39]: Cash & cash equivalents, including restricted, at beginning of year | $8,104 [SEP]\n[row 40]: Cash & cash equivalents, including restricted, at end of year | $14,647 [SEP]\n[row 41]: Less restricted cash & cash equivalents, included in Investments | $33 [SEP]\n[row 42]: Cash and cash equivalents at end of year | $14,614 [SEP]\n\n[Time]: December 31, 2021 [SEP]\n[row 0]: Cash flows \u2013 operating activities: [SEP]\n[row 1]: Net loss | $(4,290) [SEP]\n[row 2]: Share-based plans expense | $833 [SEP]\n[row 3]: Treasury shares issued for 401(k) contribution | $1,233 [SEP]\n[row 4]: Depreciation and amortization | $2,144 [SEP]\n[row 5]: Investment/asset impairment charges, net | $98 [SEP]\n[row 6]: Gain on dispositions, net | $(277) [SEP]\n[row 7]: 787 reach-forward loss | $3,460 [SEP]\n[row 8]: Other charges and credits, net | $360 [SEP]\n[row 9]: Accounts receivable | $(713) [SEP]\n[row 10]: Unbilled receivables | $(586) [SEP]\n[row 11]: Advances and progress billings | $2,505 [SEP]\n[row 12]: Inventories | $(1,127) [SEP]\n[row 13]: Other current assets | $(345) [SEP]\n[row 14]: Accounts payable | $(3,783) [SEP]\n[row 15]: Accrued liabilities | $(3,687) [SEP]\n[row 16]: Income taxes receivable, payable and deferred | $733 [SEP]\n[row 17]: Other long-term liabilities | $(206) [SEP]\n[row 18]: Pension and other postretirement plans | $(972) [SEP]\n[row 19]: Financing receivables and operating lease equipment, net | $210 [SEP]\n[row 20]: Other | $304 [SEP]\n[row 21]: Net cash provided/(used) by operating activities | $(3,416) [SEP]\n\n[row 22]: Cash flows \u2013 investing activities: [SEP]\n[row 23]: Payments to acquire property, plant and equipment | $(980) [SEP]\n[row 24]: Proceeds from disposals of property, plant and equipment | $529 [SEP]\n[row 25]: Acquisitions, net of cash acquired | $(6) [SEP]\n[row 26]: Contributions to investments | $(35,713) [SEP]\n[row 27]: Proceeds from investments | $45,489 [SEP]\n[row 28]: Other | $5 [SEP]\n[row 29]: Net cash (used)/provided by investing activities | $9,324 [SEP]\n\n[row 30]: Cash flows \u2013 financing activities: [SEP]\n[row 31]: New borrowings | $9,795 [SEP]\n[row 32]: Debt repayments | $(15,371) [SEP]\n[row 33]: Stock options exercised | $42 [SEP]\n[row 34]: Employee taxes on certain share-based payment arrangements | $(66) [SEP]\n[row 35]: Other | [SEP]\n[row 36]: Net cash used by financing activities | $(5,600) [SEP]\n\n[row 37]: Effect of exchange rate changes on cash and cash equivalents | $(39) [SEP]\n[row 38]: Net (decrease)/increase in cash & cash equivalents, including restricted | $269 [SEP]\n[row 39]: Cash & cash equivalents, including restricted, at beginning of year | $7,835 [SEP]\n[row 40]: Cash & cash equivalents, including restricted, at end of year | $8,104 [SEP]\n[row 41]: Less restricted cash & cash equivalents, included in Investments | $52 [SEP]\n[row 42]: Cash and cash equivalents at end of year | $8,052 [SEP]"]